Comprehensive Foot Examination and Risk Assessment

It is now 10 years since the last technical review on preventative foot care was published (1), which was followed by an American Diabetes Association (ADA) position statement on preventive foot care in diabetes (2). Many studies have been published proposing a range of tests that might usefully identify patients at risk of foot ulceration, creating confusion among practitioners as to which screening tests should be adopted in clinical practice. A task force was therefore assembled by the ADA to address and concisely summarize recent literature in this area and then recommend what should be included in the comprehensive foot exam for adult patients with diabetes. The committee was cochaired by the immediate past and current chairs of the ADA Foot Care Interest Group (A.J.M.B. and D.G.A.), with other panel members representing primary care, orthopedic and vascular surgery, physical therapy, podiatric medicine and surgery, and the American Association of Clinical Endocrinologists. The lifetime risk of a person with diabetes developing a foot ulcer may be as high as 25%, whereas the annual incidence of foot ulcers is ∼2% (3–7). Up to 50% of older patients with type 2 diabetes have one or more risk factors for foot ulceration (3,6). A number of component causes, most importantly peripheral neuropathy, interact to complete the causal pathway to foot ulceration (1,3–5). A list of the principal contributory factors that might result in foot ulcer development is provided in Table 1. View this table: Table 1— Risk factors for foot ulcers The most common triad of causes that interact and ultimately result in ulceration has been identified as neuropathy, deformity, and trauma (5). As identification of those patients at risk of foot problems is the first step in preventing such complications, this report will focus on key components of the …

[1]  A. Veves,et al.  The Prediction of Diabetic Neuropathic Foot Ulceration Using Vibration Perception Thresholds: A prospective study , 1994, Diabetes Care.

[2]  W. F. Todd,et al.  The Natural History of Acute Charcot’s Arthropathy in a Diabetic Foot Specialty Clinic , 1997, Journal of the American Podiatric Medical Association.

[3]  D. Armstrong,et al.  Practical criteria for screening patients at high risk for diabetic foot ulceration. , 1998, Archives of internal medicine.

[4]  D. Armstrong,et al.  Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. , 1998, Archives of internal medicine.

[5]  G. Reiber,et al.  Preventive Foot Care in People With Diabetes , 1998, Diabetes Care.

[6]  E. Boyko,et al.  Physical examination and chronic lower-extremity ischemia: a critical review. , 1998, Archives of internal medicine.

[7]  D G Smith,et al.  Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. , 1999, Diabetes care.

[8]  N. Schaper,et al.  International consensus and practical guidelines on the management and the prevention of the diabetic foot. International Working Group on the Diabetic Foot. , 2000, Diabetes/metabolism research and reviews.

[9]  Preventive foot care in people with diabetes. , 2000, Diabetes care.

[10]  J Booth,et al.  Differences in the performance of commercially available 10-g monofilaments. , 2000, Diabetes care.

[11]  J. Mayfield,et al.  The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes. , 2000, The Journal of family practice.

[12]  J. Griffiths,et al.  The North‐West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community‐based patient cohort , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[13]  N. Schaper,et al.  International consensus and practical guidelines on the management and the prevention of the diabetic foot , 2000, Current diabetes reports.

[14]  Kirk E. Smith,et al.  Forefoot structural predictors of plantar pressures during walking in people with diabetes and peripheral neuropathy. , 2003, Journal of biomechanics.

[15]  C. M. Agrawal,et al.  Home monitoring of foot skin temperatures to prevent ulceration. , 2004, Diabetes care.

[16]  J. Arezzo,et al.  Diabetic somatic neuropathies. , 2004, Diabetes care.

[17]  R. Kirsner,et al.  Clinical practice. Neuropathic diabetic foot ulcers. , 2004, The New England journal of medicine.

[18]  Andrew J.M. Boulton,et al.  Neuropathic Diabetic Foot Ulcers , 2004 .

[19]  D. Armstrong,et al.  Preventing foot ulcers in patients with diabetes. , 2005, JAMA.

[20]  A. Panju,et al.  Does the clinical examination predict lower extremity peripheral arterial disease? , 2006, JAMA.

[21]  D. Armstrong,et al.  A Supplement to : Foot & Ankle Surgery , 2006 .

[22]  David G Armstrong,et al.  Skin temperature monitoring reduces the risk for diabetic foot ulceration in high-risk patients. , 2007, The American journal of medicine.

[23]  C. M. Agrawal,et al.  Preventing Diabetic Foot Ulcer Recurrence in High-Risk Patients , 2007, Diabetes Care.

[24]  B. Thiers Prediction of Diabetic Foot Ulcer Occurrence Using Commonly Available Clinical Information: The Seattle Diabetic Foot StudyBoyko EJ, Nelson KM, Ahroni JH, et al (VA Puget Sound Health Care System, Seattle; Univ of Washington, Seattle) Diabetes Care 29:1202–1207, 2006§ , 2007 .

[25]  D. Murdoch,et al.  Reevaluating the Way We Classify the Diabetic Foot , 2008, Diabetes Care.

[26]  I. Bristow Non‐ulcerative skin pathologies of the diabetic foot , 2008, Diabetes/metabolism research and reviews.